Literature DB >> 22290231

The emerging role of stem cells in ocular neurodegeneration: hype or hope?

Neeru Jindal1, Asok Mukhopadhyay, Akshay Anand.   

Abstract

Affecting over a hundred million individuals worldwide, retinal diseases are among the leading causes of irreversible visual impairment and blindness. Thus, an appropriate study models, especially animal models, are essential to furthering our understanding of the etiology, pathology, and progression of these diseases. In this review, we provide an overview of retinal disorders in the context of biotherapeutic approaches in these disorders.

Entities:  

Mesh：

Year:  2012        PMID： 22290231     DOI： 10.1007/s11010-012-1244-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


  73 in total

1.  In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction.

Authors:  Fumitaka Osakada; Zi-Bing Jin; Yasuhiko Hirami; Hanako Ikeda; Teruko Danjyo; Kiichi Watanabe; Yoshiki Sasai; Masayo Takahashi
Journal:  J Cell Sci       Date:  2009-08-11       Impact factor: 5.285

2.  Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats.

Authors:  U Schraermeyer; G Thumann; T Luther; N Kociok; S Armhold; K Kruttwig; C Andressen; K Addicks; K U Bartz-Schmidt
Journal:  Cell Transplant       Date:  2001       Impact factor: 4.064

3.  SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

Authors:  Jason M Butler; Steven M Guthrie; Mehmet Koc; Aqeela Afzal; Sergio Caballero; H Logan Brooks; Robert N Mames; Mark S Segal; Maria B Grant; Edward W Scott
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Multipotent cells from mammalian iris pigment epithelium.

Authors:  Maki Asami; Guangwei Sun; Masahiro Yamaguchi; Mitsuko Kosaka
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

5.  Directed differentiation of human-induced pluripotent stem cells generates active motor neurons.

Authors:  Saravanan Karumbayaram; Bennett G Novitch; Michaela Patterson; Joy A Umbach; Laura Richter; Anne Lindgren; Anne E Conway; Amander T Clark; Steve A Goldman; Kathrin Plath; Martina Wiedau-Pazos; Harley I Kornblum; William E Lowry
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

6.  Persistent progenitors at the retinal margin of ptc+/- mice.

Authors:  Ala Moshiri; Thomas A Reh
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

7.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 8.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

9.  Retinal repair by transplantation of photoreceptor precursors.

Authors:  R E MacLaren; R A Pearson; A MacNeil; R H Douglas; T E Salt; M Akimoto; A Swaroop; J C Sowden; R R Ali
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494
View more
  3 in total

1.  Therapeutic effect of the mesenchymal stem cells on vigabatrin-induced retinopathy in adult male albino rat.

Authors:  Ayat Mahmoud Domouky; Walaa M Samy; Walaa A Rashad
Journal:  Anat Cell Biol       Date:  2022-06-30

2.  Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma.

Authors:  Ying Hu; Hai Bo Tan; Xin Mei Wang; Hua Rong; Hong Ping Cui; Hao Cui
Journal:  Clin Interv Aging       Date:  2013-10-31       Impact factor: 4.458

3.  Brain-Derived Neurotrophic Factor in children with Autism Spectrum Disorder.

Authors:  Nikhil J Kasarpalkar; Sweta T Kothari; Usha P Dave
Journal:  Ann Neurosci       Date:  2014-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.